Loading…

CU Medical Systems signed an agreement to acquire a 33.88% stake in Vistos from its largest shareholder and others for KRW 22 billion, gaining management rights. The acquisition aims to diversify into patient monitoring and biosignal devices.
“CU Medical Systems expressed its ambition to create synergy with Vistos and grow into a global comprehensive medical device company.”asiae.co.kr
Summarized from public sources; check the original articles before acting on it.